Syndax Pharmaceuticals Inc (SNDX): Operating Income
-$273.08M
Year ended 2025-12-31
-$194.17M
Trailing 12 months to 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$273.08M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$339.67M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$229.95M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$151.76M | n/m | 2025-03-03, From 2022-01-01 |
| 2021-12-31 | $26.22M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$71.42M | n/m | 2023-02-28, From 2020-01-01 |
| 2019-12-31 | -$57.54M | n/m | 2022-03-01, From 2019-01-01 |
| 2018-12-31 | -$75.88M | n/m | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$61.95M | n/m | 2020-03-05, From 2017-01-01 |
| 2016-12-31 | -$43.77M | n/m | 2019-03-07, From 2016-01-01 |
| 2015-12-31 | -$20.51M | n/m | 2018-03-08, From 2015-01-01 |
| 2014-12-31 | -$21.33M | n/a | 2017-03-14, From 2014-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$273.08M | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$159.99M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$36.81M | n/m |
| Lifevantage Corp (LFVN) | 2026-06-30 | $6.10M | -50.0% |
| Stoke Therapeutics, Inc. (STOK) | 2025-12-31 | -$20.59M | n/m |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 2025-12-31 | -$215.27M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$51.38M | n/m |
| Rhythm Pharmaceuticals, Inc. (RYTM) | 2025-12-31 | -$192.02M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$2.54M | n/m |
Compare SNDX, PHAT, CYRX, LFVN side by side · Screen every company in Pharmaceutical Preparations ↗